Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pelthos Therapeutics (PTHS) Other Working Capital Changes (2024 - 2025)

Pelthos Therapeutics has reported Other Working Capital Changes over the past 2 years, most recently at -$2.0 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$2.0 million for Q4 2025, down 124.72% from a year ago — trailing twelve months through Dec 2025 was -$2.7 million (changed N/A YoY), and the annual figure for FY2025 was -$589000.0, down 5401.05%.
  • Other Working Capital Changes for Q4 2025 was -$2.0 million at Pelthos Therapeutics, down from $9923.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for PTHS hit a ceiling of $220930.0 in Q1 2024 and a floor of -$2.0 million in Q4 2025.